Zvavahera Chirenje, MD

Title(s)Professor, Ob/Gyn, Reproductive Sciences
SchoolSchool of Medicine
Address550 16th Street, #3735
San Francisco CA 94158
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    • Professor (full time) University of California San Francisco, Dept of Obstetrics, Gynaecology & Reproductive Sciences, San Francisco, USA
    • Professor (voluntary) University of Zimbabwe Faculty of Medicine & Health Sciences, Harare Zimbabwe
    • Principal Investigator (PI) / Director for the University of Zimbabwe Clinical Trials Unit (UZ-UCSF CTU)

    In 1994, Dr. Chirenje was one of the founding members of the US National Institutes of Health (NIH) funded University of Zimbabwe - Clinical Trials Research Centre (UZ-CTRC), formerly University of Zimbabwe - University of California, San Francisco (UZ-UCSF) Collaborative Research Programme in Women’s Health. At this facility he conducts pivotal HIV prevention clinical trials in women with particular emphasis on Pre-Exposure Prophylaxis (PrEP) and HIV vaccine development and was instrumental in the establishment of the first HIV vaccine research capacity in Zimbabwe in 2017.

    He oversees a research unit with 276 employees in Harare, Zimbabwe and 5 support staff in San Francisco, CA, providing leadership that promotes high quality research for 4 NIH sponsored networks of ACTG, IMPAACT, HPTN and HVTN. Over the past 26 years, Dr Chirenje has overseen the development of a centralized research support unit that coordinates fiscal management and executes NIH protocols at the highest level of data capture and retention of participants with a solid track record of scientific publications that has assisted in policy implementation for Zimbabwe’s Ministry of Health

    His long-standing research focus has included evaluating the optimal performance of cervical cancer screening tests in low resource settings, cervical cancer screening and impact of HIV on HPV infections among women, finding safe and effective biomedical HIV prevention interventions for women, STI testing and treatment. Dr. Chirenje was Principal Investigator for a large protocol that screened 11,000 women in Harare, which became an international milestone study demonstrating the effectiveness of visual inspection with acetic acid (VIA) in screening for cervical cancer in low resource settings.

    Areas of interest:
    • Evaluation of cervical cancer screening & treatment modalities in low resource settings.
    • Implementation of HPV vaccination & HPV testing programmes in low resource settings.
    • Evaluation of best biomedical HIV prevention methods among women (conducting pivotal HIV prevention trials on PrEP).
    • Conducting HIV vaccine safety & efficacy trials.
    • Conducting COVID-19 vaccine safety & efficacy trials.
    Collapse Global Health Equity

    Collapse Research 
    Collapse Research Activities and Funding
    Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
    NIH UG1CA284918Aug 4, 2023 - May 31, 2027
    Role: Principal Investigator
    The Bixby Center for Global Reproductive Health - Annual Research Day Conference
    NIH R13AI132016Aug 1, 2017 - Jul 31, 2018
    Role: Principal Investigator
    NIH UM1AI069436Mar 1, 2007 - Nov 30, 2027
    Role: Principal Investigator
    UZ-UCSF Clinical Trials Unit
    NIH U01AI069436Mar 1, 2007 - Nov 30, 2013
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The Impact of DNA Tumor Viruses in low-to-middle income countries (LMICS): a literature review. Tumour Virus Res. 2024 Jul 06; 200289. Guzha BT, Matubu A, Nyandoro G, Mubata HO, Moyo E, Murewanhema G, Chirenje ZM. PMID: 38977263.
      View in: PubMed   Mentions:
    2. Efficient regulatory approval of two novel HIV prevention interventions in a resource-limited setting: experiences from Zimbabwe. Front Reprod Health. 2023; 5:1279124. Murombedzi C, Chirinda L, Chareka GT, Chirenje ZM, Mgodi NM. PMID: 38034413; PMCID: PMC10682080.
      View in: PubMed   Mentions:
    3. Protein dose-sparing effect of AS01B adjuvant in a randomized preventive HIV vaccine trial of ALVAC-HIV (vCP2438) and adjuvanted bivalent subtype C gp120. J Infect Dis. 2023 Oct 05. Chirenje ZM, Laher F, Dintwe O, Muyoyeta M, deCamp AC, He Z, Grunenberg N, Laher Omar F, Seaton KE, Polakowski L, Woodward Davis AS, Maganga L, Baden LR, Mayer K, Kalams S, Keefer M, Edupuganti S, Rodriguez B, Frank I, Scott H, Stranix-Chibanda L, Gurunathan S, Koutsoukos M, Van Der Meeren O, DiazGranados CA, Paez C, Andersen-Nissen E, Kublin J, Corey L, Ferrari G, Tomaras G, McElrath MJ, HVTN120 study team. PMID: 37795976.
      View in: PubMed   Mentions:    Fields:    
    4. Antenatal depression: Associations with birth and neonatal outcomes among women attending maternity care in Harare, Zimbabwe. PLoS One. 2023; 18(7):e0270873. Kaiyo-Utete M, Langhaug L, Chingono A, Dambi JM, Magwali T, Henderson C, Chirenje ZM. PMID: 37418441; PMCID: PMC10328234.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Strategic actions to advance multipurpose prevention technologies in low- and middle-income countries. Front Reprod Health. 2023; 5:1150857. Young Holt B, van der Straten A, Barker T, Chirenje ZM, Cameron AI, Scott C, Casas CP, Romano J. PMID: 37465533; PMCID: PMC10351869.
      View in: PubMed   Mentions: 2  
    6. Population-Level Correlation Between Incidence of Curable Sexually Transmitted Infections and Human Immunodeficiency Virus (HIV)-1 Among African Women Participating in HIV-1 Pre-Exposure Prophylaxis Trials. J Infect Dis. 2022 09 21; 226(6):1069-1074. Hunidzarira P, Brown ER, Chirenje ZM, Hillier SL, Marrazzo JM, Palanee-Phillips T, Kiweewa FM, Baeten JM, MTN-003/VOICE and MTN-020/ASPIRE Study Teams. PMID: 35763413; PMCID: PMC10233491.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    7. Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial. Lancet HIV. 2022 10; 9(10):e680-e689. Velloza J, Donnell D, Hosek S, Anderson PL, Chirenje ZM, Mgodi N, Bekker LG, Marzinke MA, Delany-Moretlwe S, Celum C. PMID: 36087612; PMCID: PMC9530001.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    8. Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022. Vaccine. 2022 09 29; 40(41):5843-5855. Prudden HJ, Achilles SL, Schocken C, Broutet N, Canfell K, Akaba H, Basu P, Bhatla N, Chirenje ZM, Delany-Moretlwe S, Denny L, Gamage DG, Herrero R, Hutubessy R, Villa LL, Murillo R, Schiller JT, Stanley M, Temmerman M, Zhao F, Ogilvie G, Kaslow DC, Dull P, Gottlieb SL, Therapeutic HPV Vaccine PPC Expert Consultation Group*. PMID: 36008233.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    9. Patient experiences of living with cancer before interaction with palliative care services in Zimbabwe: A qualitative secondary data analysis. Eur J Cancer Care (Engl). 2022 Sep; 31(5):e13632. Dandadzi A, Chapman E, Chirenje ZM, Namukwaya E, Pini S, Nkhoma K, Allsop MJ. PMID: 35712980; PMCID: PMC9542205.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence. EClinicalMedicine. 2022 Mar; 45:101306. Liu G, Mugo NR, Bayer C, Rao DW, Onono M, Mgodi NM, Chirenje ZM, Njoroge BW, Tan N, Bukusi EA, Barnabas RV. PMID: 35243272; PMCID: PMC8860915.
      View in: PubMed   Mentions: 10  
    11. Prevalent human papillomavirus infection increases the risk of HIV acquisition in African women: advancing the argument for human papillomavirus immunization. AIDS. 2022 02 01; 36(2):257-265. Liu G, Mugo NR, Brown ER, Mgodi NM, Chirenje ZM, Marrazzo JM, Winer RL, Mansoor L, Palanee-Phillips T, Siva SS, Naidoo L, Jeenarain N, Gaffoor Z, Nair GL, Selepe P, Nakabiito C, Mkhize B, Mirembe BG, Taljaard M, Panchia R, Baeten JM, Balkus JE, Hladik F, Celum CL, Barnabas RV. PMID: 34172672; PMCID: PMC8702475.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    12. The IARC Perspective on Cervical Cancer Screening. N Engl J Med. 2021 11 11; 385(20):1908-1918. Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P, Kupets R, Smith R, Arrossi S, Bendahhou K, Canfell K, Chirenje ZM, Chung MH, Del Pino M, de Sanjosé S, Elfström M, Franco EL, Hamashima C, Hamers FF, Herrington CS, Murillo R, Sangrajrang S, Sankaranarayanan R, Saraiya M, Schiffman M, Zhao F, Arbyn M, Prendiville W, Indave Ruiz BI, Mosquera-Metcalfe I, Lauby-Secretan B. PMID: 34758259.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansPHPublic Health
    13. Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa. Front Reprod Health. 2021 Jul; 3. Noguchi LM, Marrazzo JM, Richardson B, Hillier SL, Balkus JE, Palanee-Phillips T, Nair G, Panchia R, Piper J, Gomez K, Ramjee G, Chirenje ZM. PMID: 35669097; PMCID: PMC9165437.
      View in: PubMed   Mentions: 1  
    14. Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping. PLoS One. 2021; 16(4):e0250426. Dube Mandishora RS, Rounge TB, Fitzpatrick M, Christiansen IK, Ambur OH, Lagström S, Stray-Pedersen B, Tommasino M, Palefsky J, Chirenje ZM. PMID: 33901223; PMCID: PMC8075200.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    15. Effect of injectable progestin-only contraceptives, depot medroxyprogesterone acetate and norethisterone enanthate, on cytokine production during T-cell activation. Am J Reprod Immunol. 2021 07; 86(1):e13405. Matubu AT, Hillier SL, Meyn LA, Stoner KA, Mhlanga F, Mbizvo M, Maramba A, Chirenje ZM, Achilles SL. PMID: 33609312.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    16. Treatment approaches for women with positive cervical screening results in low-and middle-income countries. Prev Med. 2021 03; 144:106439. Wentzensen N, Chirenje ZM, Prendiville W. PMID: 33678236.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    17. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. Lancet HIV. 2021 02; 8(2):e87-e95. Baeten JM, Palanee-Phillips T, Mgodi NM, Mayo AJ, Szydlo DW, Ramjee G, Gati Mirembe B, Mhlanga F, Hunidzarira P, Mansoor LE, Siva S, Govender V, Makanani B, Naidoo L, Singh N, Nair G, Chinula L, Parikh UM, Mellors JW, Balán IC, Ngure K, van der Straten A, Scheckter R, Garcia M, Peda M, Patterson K, Livant E, Bunge K, Singh D, Jacobson C, Jiao Y, Hendrix CW, Chirenje ZM, Nakabiito C, Taha TE, Jones J, Torjesen K, Nel A, Rosenberg Z, Soto-Torres LE, Hillier SL, Brown ER, MTN-025/HOPE Study Team. PMID: 33539762; PMCID: PMC8038210.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCellsCTClinical Trials
    18. Preferences and Acceptability of Vaginal Delivery Forms for HIV Prevention Among Women, Male Partners and Key Informants in South Africa and Zimbabwe: Qualitative Findings. AIDS Behav. 2021 Jan; 25(1):124-138. Musara P, Milford C, Shapley-Quinn MK, Weinrib R, Mutero P, Odoom E, Mgodi NM, Chirenje ZM, Hanif H, Clark MR, Smit J, van der Straten A, Montgomery ET, Quatro Study Team. PMID: 32588257.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    19. Estimated costs for the delivery of safer conception strategies for HIV-discordant couples in Zimbabwe: a cost analysis. BMC Health Serv Res. 2020 Oct 12; 20(1):940. Hughes CS, Brown J, Murombedzi C, Chirenda T, Chareka G, Mhlanga F, Mateveke B, Gitome S, Makurumure T, Matubu A, Mgodi N, Chirenje Z, Kahn JG. PMID: 33046066; PMCID: PMC7552466.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    20. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe. BMC Womens Health. 2020 07 25; 20(1):153. Fitzpatrick M, Pathipati MP, McCarty K, Rosenthal A, Katzenstein D, Chirenje ZM, Pinsky B. PMID: 32711530; PMCID: PMC7382027.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsPHPublic Health
    21. Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives. Am J Reprod Immunol. 2020 09; 84(3):e13287. Achilles SL, Meyn LA, Mhlanga FG, Matubu AT, Stoner KA, Beamer MA, Chirenje ZM, Hillier SL. PMID: 32533883; PMCID: PMC7507197.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    22. Efficacy is Not Everything: Eliciting Women's Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice Experiment. AIDS Behav. 2020 May; 24(5):1443-1451. Browne EN, Montgomery ET, Mansfield C, Boeri M, Mange B, Beksinska M, Schwartz JL, Clark MR, Doncel GF, Smit J, Chirenje ZM, van der Straten A. PMID: 31696371; PMCID: PMC6990865.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    23. Antenatal depression: an examination of prevalence and its associated factors among pregnant women attending Harare polyclinics. BMC Pregnancy Childbirth. 2020 Apr 06; 20(1):197. Kaiyo-Utete M, Dambi JM, Chingono A, Mazhandu FSM, Madziro-Ruwizhu TB, Henderson C, Magwali T, Langhaug L, Chirenje ZM. PMID: 32252675; PMCID: PMC7137411.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    24. Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities. AIDS. 2020 03 15; 34(4):559-567. Reddy K, Kelly C, Brown ER, Jeenarain N, Naidoo L, Siva S, Bekker LG, Nair G, Makanani B, Chinula L, Mgodi N, Chirenje Z, Kiweewa FM, Marrazzo J, Bunge K, Soto-Torres L, Piper J, Baeten JM, Palanee-Phillips T, MTN-020/ASPIRE and MTN-003/VOICE Study Teams. PMID: 31764068; PMCID: PMC7262458.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    25. Mentored postdoctoral training in Zimbabwe: A report on a successful collaborative effort. J Public Health Afr. 2019 Dec 31; 10(2):1081. Zhou DT, Maponga CC, Madhombiro M, Dube A, Mano R, Nyamhunga A, Machingura I, Manasa J, Hakim J, Chirenje ZM, Mudzviti T, Nhachi C, Ma Q, DiFrancesco R, Masanganise R, Morse GD. PMID: 32257079; PMCID: PMC7118437.
      View in: PubMed   Mentions: 4  
    26. Depot medroxyprogesterone acetate and norethisterone enanthate differentially impact T-cell responses and expression of immunosuppressive markers. Am J Reprod Immunol. 2020 03; 83(3):e13210. Matubu A, Hillier SL, Meyn LA, Stoner KA, Mhlanga F, Mbizvo M, Maramba A, Chirenje ZM, Achilles SL. PMID: 31729087; PMCID: PMC7900783.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    27. Human papillomavirus genotype distribution in genital warts among women in Harare-Zimbabwe. J Obstet Gynaecol. 2020 Aug; 40(6):830-836. Manyere NR, Dube Mandishora RS, Magwali T, Mtisi F, Mataruka K, Mtede B, Palefsky JM, Chirenje ZM. PMID: 31790323.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    28. Social harms in female-initiated HIV prevention method research: state of the evidence. AIDS. 2019 11 15; 33(14):2237-2244. Montgomery ET, Roberts ST, Nel A, Malherbe M, Torjesen K, Bunge K, Singh D, Baeten JM, Marrazzo J, Chirenje ZM, Kabwigu S, Beigi R, Riddler SA, Gaffour Z, Reddy K, Mansoor LE, Nair G, Woeber K, Moodley J, Jeenarain N, Siva S, Naidoo L, Govender V, Palanee-Phillips T. PMID: 31408030; PMCID: PMC6832829.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    29. Understanding data and information needs for palliative cancer care to inform digital health intervention development in Nigeria, Uganda and Zimbabwe: protocol for a multicountry qualitative study. BMJ Open. 2019 10 31; 9(10):e032166. Okunade K, Bashan Nkhoma K, Salako O, Akeju D, Ebenso B, Namisango E, Soyannwo O, Namukwaya E, Dandadzi A, Nabirye E, Mupaza L, Luyirika E, Ddungu H, Chirenje ZM, Bennett MI, Harding R, Allsop MJ. PMID: 31676657; PMCID: PMC6830840.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    30. Giant mucinous cystadenoma: a case report. J Med Case Rep. 2019 Jun 14; 13(1):181. Gwanzura C, Muyotcha AF, Magwali T, Chirenje ZM, Madziyire MG. PMID: 31196215; PMCID: PMC6567598.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    31. Community-based self-collected human papillomavirus screening in rural Zimbabwe. BMC Public Health. 2019 May 29; 19(Suppl 1):603. Fitzpatrick MB, El-Khatib Z, Katzenstein D, Pinsky BA, Chirenje ZM, McCarty K. PMID: 31138174; PMCID: PMC6538544.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    32. Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial. J Infect Dis. 2019 05 24; 219(12):1940-1947. Marrazzo JM, Rabe L, Kelly C, Richardson B, Deal C, Schwartz JL, Chirenje ZM, Piper J, Morrow RA, Hendrix CW, Marzinke MA, Hillier SL, VOICE Study Team. PMID: 30753642; PMCID: PMC6534189.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsPHPublic Health
    33. End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study. J Int AIDS Soc. 2019 05; 22(5):e25283. Montgomery ET, Beksinska M, Mgodi N, Schwartz J, Weinrib R, Browne EN, Mphili N, Musara P, Jaggernath M, Ju S, Smit J, Chirenje ZM, Doncel GF, van der Straten A. PMID: 31069957; PMCID: PMC6506690.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    34. hrHPV prevalence and type distribution in rural Zimbabwe: A community-based self-collection study using near-point-of-care GeneXpert HPV testing. Int J Infect Dis. 2019 May; 82:21-29. Fitzpatrick MB, Dube Mandishora RS, Katzenstein DA, McCarty K, Weber J, Sahoo MK, Manasa J, Chirenje ZM, Pinsky BA. PMID: 30807869; PMCID: PMC6538272.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsPHPublic Health
    35. A case of twin reversed arterial perfusion (TRAP) sequence managed conservatively. Pan Afr Med J. 2019; 32:54. Ziki EM, Chirenje ZM, Madziyire MG. PMID: 31143359; PMCID: PMC6522165.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    36. Validation of the GenoType® MTBDRplus Ver 2.0 assay for detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates at UZCHS-CTRC TB research laboratory. Int J Mycobacteriol. 2019 Jan-Mar; 8(1):83-88. Stephen S, Muzhizhizhi D, Dhibi N, Chidemo T, Samaneka W, Matubu TA, Hakim JG, Chirenje ZM. PMID: 30860184.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    37. Anal human papillomavirus infection in HIV-positive men and women at two opportunistic infections clinics in Harare, Zimbabwe. BMC Public Health. 2018 Nov 14; 18(1):1260. Chinyowa S, Palefsky JM, Chirenje ZM, Makunike-Mutasa R, Munjoma M, Muguti GI. PMID: 30428859; PMCID: PMC6237038.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    38. The association of puerperal sepsis with HIV infection at two tertiary hospitals in Zimbabwe. Int J Gynaecol Obstet. 2019 Jan; 144(1):67-72. Majangara R, Chirenje ZM, Gidiri MF. PMID: 30343490; PMCID: PMC6283678.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. HIV infection in patients with sexually transmitted infections in Zimbabwe - Results from the Zimbabwe STI etiology study. PLoS One. 2018; 13(6):e0198683. Kilmarx PH, Gonese E, Lewis DA, Chirenje ZM, Barr BAT, Latif AS, Gwanzura L, Handsfield HH, Machiha A, Mugurungi O, Rietmeijer CA. PMID: 29889865; PMCID: PMC5995434.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    40. The Etiology of Vaginal Discharge Syndrome in Zimbabwe: Results from the Zimbabwe STI Etiology Study. Sex Transm Dis. 2018 06; 45(6):422-428. Chirenje ZM, Dhibi N, Handsfield HH, Gonese E, Tippett Barr B, Gwanzura L, Latif AS, Maseko DV, Kularatne RS, Tshimanga M, Kilmarx PH, Machiha A, Mugurungi O, Rietmeijer CA. PMID: 29465674; PMCID: PMC6879447.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    41. Impact of contraceptive initiation on vaginal microbiota. Am J Obstet Gynecol. 2018 06; 218(6):622.e1-622.e10. Achilles SL, Austin MN, Meyn LA, Mhlanga F, Chirenje ZM, Hillier SL. PMID: 29505773; PMCID: PMC5990849.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    42. How Presentation of Drug Detection Results Changed Reports of Product Adherence in South Africa, Uganda and Zimbabwe. AIDS Behav. 2018 03; 22(3):877-886. Musara P, Montgomery ET, Mgodi NM, Woeber K, Akello CA, Hartmann M, Cheng H, Levy L, Katz A, Grossman CI, Chirenje ZM, van der Straten A, Mensch B, Microbicide Trials Network-003D Study Team. PMID: 28110473; PMCID: PMC5587392.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    43. Microbiology and clinical outcomes of puerperal sepsis: a prospective cohort study. J Obstet Gynaecol. 2018 Jul; 38(5):635-641. Majangara R, Gidiri MF, Chirenje ZM. PMID: 29447024.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    44. Misreporting of contraceptive hormone use in clinical research participants. Contraception. 2018 04; 97(4):346-353. Achilles SL, Mhlanga FG, Musara P, Poloyac SM, Chirenje ZM, Hillier SL. PMID: 28966052; PMCID: PMC5858917.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    45. The fourth generation AlereTM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples. J Clin Virol. 2017 09; 94:15-21. Livant E, Heaps A, Kelly C, Maharaj R, Samsunder N, Nhlangulela L, Karugaba P, Panchia R, Marrazzo J, Chirenje ZM, Parikh UM, VOICE Study Team. PMID: 28710996; PMCID: PMC5790424.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    46. Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe. J Med Virol. 2017 09; 89(9):1671-1677. Dube Mandishora RS, Christiansen IK, Chin'ombe N, Duri K, Ngara B, Rounge TB, Meisal R, Ambur OH, Palefsky JM, Stray-Pedersen B, Chirenje ZM. PMID: 28390142.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    47. Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations. AIDS Res Hum Retroviruses. 2017 08; 33(8):778-783. Koss CA, Bacchetti P, Hillier SL, Livant E, Horng H, Mgodi N, Mirembe BG, Gomez Feliciano K, Horn S, Liu AY, Glidden DV, Grant RM, Benet LZ, Louie A, van der Straten A, Chirenje ZM, Marrazzo JM, Gandhi M. PMID: 28253024; PMCID: PMC5564054.
      View in: PubMed   Mentions: 43     Fields:    
    48. Risk Factors for Incidence of Sexually Transmitted Infections Among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003). Sex Transm Dis. 2017 03; 44(3):135-140. Chirenje ZM, Gundacker HM, Richardson B, Rabe L, Gaffoor Z, Nair GL, Mirembe BG, Piper JM, Hillier S, Marrazzo J. PMID: 28178109; PMCID: PMC5535309.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    49. Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial. J Womens Health (Larchmt). 2017 06; 26(6):670-676. Akello CA, Bunge KE, Nakabiito C, Mirembe BG, Fowler MG, Mishra A, Marrazzo J, Chirenje ZM, Celum C, Balkus JE. PMID: 28437215; PMCID: PMC5512296.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    50. Adult Hematology and Clinical Chemistry Laboratory Reference Ranges in a Zimbabwean Population. PLoS One. 2016; 11(11):e0165821. Samaneka WP, Mandozana G, Tinago W, Nhando N, Mgodi NM, Bwakura-Dangarembizi MF, Munjoma MW, Gomo ZA, Chirenje ZM, Hakim JG. PMID: 27812172; PMCID: PMC5094654.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    51. Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit? AIDS Behav. 2016 11; 20(11):2654-2661. Mensch BS, Brown ER, Liu K, Marrazzo J, Chirenje ZM, Gomez K, Piper J, Patterson K, van der Straten A. PMID: 26906023; PMCID: PMC5354168.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    52. Healthcare providers' perspectives on the acceptability and uptake of HPV vaccines in Zimbabwe. J Psychosom Obstet Gynaecol. 2016 12; 37(4):147-155. Crann SE, Barata PC, Mitchell R, Mawhinney L, Thistle P, Chirenje ZM, Stewart DE. PMID: 27400371.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    53. An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women. J Acquir Immune Defic Syndr. 2016 07 01; 72(3):333-43. Balkus JE, Brown E, Palanee T, Nair G, Gafoor Z, Zhang J, Richardson BA, Chirenje ZM, Marrazzo JM, Baeten JM. PMID: 26918545; PMCID: PMC4911322.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansCells
    54. Corrigendum to "oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial" [Contraception 2016; 93 (1): 25-31]. Contraception. 2016 Jul; 94(1):95. Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L, Abdool Karim SS, Chirenje ZM. PMID: 27085419.
      View in: PubMed   Mentions:    Fields:    
    55. Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis. J Acquir Immune Defic Syndr. 2016 Mar 01; 71(3):287-94. Mirembe BG, Kelly CW, Mgodi N, Greenspan S, Dai JY, Mayo A, Piper J, Akello CA, Kiweewa FM, Magure T, Nakabiito C, Marrazzo JM, Chirenje ZM, Riddler SA, MTN-003B Protocol Team. PMID: 26866954; PMCID: PMC4755358.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansPHPublic Health
    56. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. N Engl J Med. 2016 12 01; 375(22):2121-2132. Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, Matovu Kiweewa F, Nair G, Mhlanga F, Siva S, Bekker LG, Jeenarain N, Gaffoor Z, Martinson F, Makanani B, Pather A, Naidoo L, Husnik M, Richardson BA, Parikh UM, Mellors JW, Marzinke MA, Hendrix CW, van der Straten A, Ramjee G, Chirenje ZM, Nakabiito C, Taha TE, Jones J, Mayo A, Scheckter R, Berthiaume J, Livant E, Jacobson C, Ndase P, White R, Patterson K, Germuga D, Galaska B, Bunge K, Singh D, Szydlo DW, Montgomery ET, Mensch BS, Torjesen K, Grossman CI, Chakhtoura N, Nel A, Rosenberg Z, McGowan I, Hillier S, MTN-020–ASPIRE Study Team. PMID: 26900902; PMCID: PMC4993693.
      View in: PubMed   Mentions: 417     Fields:    Translation:HumansCellsCTClinical Trials
    57. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial. Contraception. 2016 Jan; 93(1):25-31. Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L, Abdool Karim SS, Chirenje ZM. PMID: 26519646; PMCID: PMC4688130.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    58. Age-Disparate Partnerships and Risk of HIV-1 Acquisition Among South African Women Participating in the VOICE Trial. J Acquir Immune Defic Syndr. 2015 Oct 01; 70(2):212-7. Balkus JE, Nair G, Montgomery ET, Mishra A, Palanee-Phillips T, Ramjee G, Panchia R, Selepe P, Richardson BA, Chirenje ZM, Marrazzo JM. PMID: 26049280; PMCID: PMC4573287.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    59. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. Lancet HIV. 2015 Jul; 2(7):e279-87. Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje ZM, Bunge K, Ramjee G, Nair G, Palanee-Phillips T, Selepe P, van der Straten A, Parikh UM, Gomez K, Piper JM, Watts DH, Marrazzo JM, VOICE Study Team. PMID: 26155597; PMCID: PMC4491329.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    60. Pharmacological Measures of Treatment Adherence and Risk of HIV Infection in the VOICE Study. J Infect Dis. 2016 Feb 01; 213(3):335-42. Dai JY, Hendrix CW, Richardson BA, Kelly C, Marzinke M, Chirenje ZM, Marrazzo JM, Brown ER. PMID: 26123563; PMCID: PMC4704663.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansPHPublic Health
    61. Factors associated with bone mineral density in healthy African women. Arch Osteoporos. 2015; 10:206. Mgodi NM, Kelly C, Gati B, Greenspan S, Dai JY, Bragg V, Livant E, Piper JM, Nakabiito C, Magure T, Marrazzo JM, Chirenje ZM, Riddler SA, MTN-003B Protocol Team. PMID: 25680424; PMCID: PMC4564062.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    62. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015 Feb 05; 372(6):509-18. Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L, Hendrix CW, Dai JY, Ganesh S, Mkhize B, Taljaard M, Parikh UM, Piper J, Mâsse B, Grossman C, Rooney J, Schwartz JL, Watts H, Marzinke MA, Hillier SL, McGowan IM, Chirenje ZM, VOICE Study Team. PMID: 25651245; PMCID: PMC4341965.
      View in: PubMed   Mentions: 724     Fields:    Translation:HumansCellsPHPublic Health
    63. Hematological and biochemical laboratory reference intervals for Zimbabwean adolescents. Clin Lab. 2015; 61(1-2):101-11. Gomani P, Matubu AT, Mujuru HA, Munjoma MW, Tinago W, Mandozana G, Hakim JG, Gomo ZA, Chirenje ZM. PMID: 25807644.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    64. Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010. Int J Cancer. 2013 Aug 01; 133(3):721-9. Chokunonga E, Borok MZ, Chirenje ZM, Nyakabau AM, Parkin DM. PMID: 23364833.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    65. Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. J Infect Dis. 2012 Dec 15; 206(12):1931-5. Dezzutti CS, Richardson BA, Marrazzo JM, Tugetman J, Ramjee G, Taha T, Chirenje ZM, Abdool Karim SS, Hillier SL, Herold BC, MTN Biomedical Sciences Working Group, HPTN 035 Protocol Team. PMID: 22966121; PMCID: PMC3502373.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    66. Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel. J Int AIDS Soc. 2012 Aug 27; 15(2):17376. Chirenje ZM, Mâsse BR, Maslankowski LA, Ramjee G, Coletti AS, Tembo TN, Magure TM, Soto-Torres L, Kelly C, Hillier S, Karim A. PMID: 22944480; PMCID: PMC3494172.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    67. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS. 2011 Apr 24; 25(7):957-66. Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, Taha T, Kapina M, Maslankowski L, Coletti A, Profy A, Moench TR, Piwowar-Manning E, Mâsse B, Hillier SL, Soto-Torres L, HIV Prevention Trials Network (HPTN) 035 Study Team. PMID: 21330907; PMCID: PMC3083640.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCellsCTClinical Trials
    68. Cancer survival in Harare, Zimbabwe, 1993-1997. IARC Sci Publ. 2011; (162):249-55. Chokunonga E, Borok MZ, Chirenje ZM, Nyabakau AM, Parkin DM. PMID: 21675430.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    69. Antiretroviral-based HIV prevention strategies for women. Expert Rev Anti Infect Ther. 2010 Oct; 8(10):1177-86. Chirenje ZM, Marrazzo J, Parikh UM. PMID: 20954882; PMCID: PMC4381115.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    70. Compliance and loss to follow up of HIV negative and positive mothers recruited from a PMTCT programme in Zimbabwe. Cent Afr J Med. 2007 May-Aug; 53(5-8):25-30. Kurewa NE, Munjoma MM, Chirenje ZM, Rusakaniko S, Hussain A, Stray-Pedersen B. PMID: 20355678.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    71. Acceptability of heat treating breast milk to prevent mother-to-child transmission of human immunodeficiency virus in Zimbabwe: a qualitative study. J Hum Lact. 2006 Feb; 22(1):48-60. Israel-Ballard KA, Maternowska MC, Abrams BF, Morrison P, Chitibura L, Chipato T, Chirenje ZM, Padian NS, Chantry CJ. PMID: 16467287.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsPHPublic Health
    72. HIV and cancer of the cervix. Best Pract Res Clin Obstet Gynaecol. 2005 Apr; 19(2):269-76. Chirenje ZM. PMID: 15778115.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    73. The CONRAD/WHO Update 2000 colposcopy manual: how well is it working? J Acquir Immune Defic Syndr. 2004 Oct; 37 Suppl 3:S150-1. Njoroge B, Chirenje ZM, Pandey B, Mirembe F, Joshi S, Low-Beer N, Maslankowski LA. PMID: 16419263.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. Bacterial vaginosis and intravaginal practices: association with HIV. Cent Afr J Med. 2004 May-Jun; 50(5-6):41-6. Mbizvo ME, Musya SE, Stray-Pedersen B, Chirenje Z, Hussain A. PMID: 15881309.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    75. Situation analysis for cervical cancer diagnosis and treatment in east, central and southern African countries. Bull World Health Organ. 2001; 79(2):127-32. Chirenje ZM, Rusakaniko S, Kirumbi L, Ngwalle EW, Makuta-Tlebere P, Kaggwa S, Mpanju-Shumbusho W, Makoae L. PMID: 11242819; PMCID: PMC2566349.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    76. Cancer of the cervix: knowledge, beliefs and screening behaviours of health workers in Mudzi District in Mashonaland East Province, Zimbabwe. Cent Afr J Med. 2003 Jul-Aug; 49(7-8):83-6. Tarwireyi F, Chirenje ZM, Rusakaniko S. PMID: 15214279.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    77. Effect of HIV Disease in Treatment Outcome of Cervical Squamous Intraepithelial Lesions Among Zimbabwean Women. J Low Genit Tract Dis. 2003 Jan; 7(1):16-21. Chirenje ZM, Rusakaniko S, Akino V, Munjoma M, Mlingo M. PMID: 17051039.
      View in: PubMed   Mentions: 11     Fields:    
    78. Association of cervical SIL and HIV-1 infection among Zimbabwean women in an HIV/STI prevention study. Int J STD AIDS. 2002 Nov; 13(11):765-8. Chirenje ZM, Loeb L, Mwale M, Nyamapfeni P, Kamba M, Padian N. PMID: 12437897.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    79. A randomised clinical trial of loop electrosurgical excision procedure (LEEP) versus cryotherapy in the treatment of cervical intraepithelial neoplasia. J Obstet Gynaecol. 2001 Nov; 21(6):617-21. Chirenje ZM, Rusakaniko S, Akino V, Mlingo M. PMID: 12521783.
      View in: PubMed   Mentions: 27     Fields:    Translation:CTClinical Trials
    80. Topical vaginal microbicides in HIV/STI prevention. Cent Afr J Med. 2001 Aug; 47(8):209-10. Chirenje ZM. PMID: 12808769.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    81. Determinants of reproductive tract infections among asymptomatic women in Harare, Zimbabwe. Cent Afr J Med. 2001 Mar; 47(3):57-64. Mbizvo EM, Msuya SE, Stray-Pedersen B, Sundby J, Chirenje ZM, Hussain A. PMID: 11961859.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    82. Situational analysis for diagnosis and treatment of cervical cancer in mainland Tanzania. East Afr Med J. 2001 Feb; 78(2):60-4. Ngwalle EW, Mgaya HN, Mpanju-Shumbusho W, Chirenje ZM, Kirumbi L, Lebelle T, Kaggwa S. PMID: 11682947.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    83. Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites. J Acquir Immune Defic Syndr. 2001 Jan 01; 26(1):21-7. van De Wijgert J, Fullem A, Kelly C, Mehendale S, Rugpao S, Kumwenda N, Chirenje Z, Joshi S, Taha T, Padian N, Bollinger R, Nelson K. PMID: 11176265.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCTClinical Trials
    84. Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear. Int J Gynaecol Obstet. 2001 Jan; 72(1):47-53. Blumenthal PD, Gaffikin L, Chirenje ZM, McGrath J, Womack S, Shah K. PMID: 11146077.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsPHPublic Health
    85. The management of cervical intra-epithelial neoplasia. Cent Afr J Med. 2000 Nov; 46(11):309-10. Chirenje Z. PMID: 12002122.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    86. A review of cervical cancer patients presenting in Harare and Parirenyatwa Hospitals in 1998. Cent Afr J Med. 2000 Oct; 46(10):264-7. Chirenje ZM, Rusakaniko S, Akino V, Mlingo M. PMID: 11682933.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    87. Effect of intravaginal practices on the vaginal and cervical mucosa of Zimbabwean women. J Acquir Immune Defic Syndr. 2000 May 01; 24(1):62-7. van de Wijgert JH, Chirenje ZM, Iliff V, Mbizvo MT, Mason PR, Gwanzura L, Shiboski S, Padian NS. PMID: 10877497.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    88. Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women. J Infect Dis. 2000 Feb; 181(2):587-94. van De Wijgert JH, Mason PR, Gwanzura L, Mbizvo MT, Chirenje ZM, Iliff V, Shiboski S, Padian NS. PMID: 10669342.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCellsPHPublic Health
    89. HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer. 2000 Jan 15; 85(2):206-10. Womack SD, Chirenje ZM, Gaffikin L, Blumenthal PD, McGrath JA, Chipato T, Ngwalle S, Munjoma M, Shah KV. PMID: 10629079.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCellsPHPublic Health
    90. Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe. BJOG. 2000 Jan; 107(1):33-8. Womack SD, Chirenje ZM, Blumenthal PD, Gaffikin L, McGrath JA, Chipato T, Ngwalle E, Shah KV. PMID: 10645859.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsPHPublic Health
    91. Visual inspection of the cervix as a primary means of cervical cancer screening: results of a pilot study. Cent Afr J Med. 1999 Feb; 45(2):30-3. Chirenje ZM, Chipato T, Kasule J, Rusakaniko S. PMID: 10444896.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    92. Situation analysis for cervical cancer diagnosis and treatment in Zimbabwe. Cent Afr J Med. 1998 Dec; 44(12):307-10. Chirenje ZM, Rusakaniko S, Chipato T, Mpanju-Shumbusho W, Ngwalle E, Kirumbi LW, Makuta-Tlebere P, Kaggwa S. PMID: 10921202.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    93. Cervical cancer screening in a rural population of Zimbabwe. Cent Afr J Med. 1997 Sep; 43(9):246-51. Thistle PJ, Chirenje ZM. PMID: 9509642.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    94. Management of the patient with an abnormal Papanicolaou smear. Cent Afr J Med. 1994 May; 40(5):131-4. Chirenje ZM. PMID: 7954725.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    95. Screening for cervical cancer: experience from the Colposcopy Clinic at Harare Hospital. Cent Afr J Med. 1993 Nov; 39(11):222-4. Chirenje ZM, Akino V. PMID: 8055551.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    Zvavahera's Networks
    Concepts (353)
    Derived automatically from this person's publications.
    Co-Authors (13)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department